Stop Stalling Access to Affordable Medications
Bill journey · stage 1 of 5
Just introduced
What it doesSummary introduced in house (Apr 28, 2021)
Stop Stalling Access to Affordable Medications
This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.
The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
What just happenedSep 29, 2021
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
Who’s behind it
- Introduced in HouseApr 28, 2021
- Sep 29, 2021Committee
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
Judiciary Committee - Sep 29, 2021Committee
Committee Consideration and Mark-up Session Held.
Judiciary Committee - Apr 28, 2021IntroReferralH11100
Referred to the House Committee on the Judiciary.
Judiciary Committee - Apr 28, 2021IntroReferralIntro-H
Introduced in House
- Apr 28, 2021IntroReferral1000
Introduced in House